<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01841346</url>
  </required_header>
  <id_info>
    <org_study_id>JoPCR1-12-12-12</org_study_id>
    <nct_id>NCT01841346</nct_id>
  </id_info>
  <brief_title>The First Jordanian PCI Registry: Events at 1 Year</brief_title>
  <acronym>JoPCR1</acronym>
  <official_title>The First Jordanian Percutaneous Coronary Intervention (PCI) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jordan Collaborating Cardiology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Jordan Collaborating Cardiology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will look at the short- (in hospital) and long- term ( 1 year)outcome in
      consecutive patients who undergo stent implantation and angioplasty in Jordan.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Voluntary registry of consecutive patients undergoing Percutaneous coronary intervention
           (PCI).

        2. Patients will be treated according to the treating cardiologists' discretion. No
           randomization of any medication or stent.

        3. Baseline data on admission will be collected (cardiovascular risk factors, blood lipids,
           ect).

        4. PCI procedure details and complications will be documented during the index admission.

        5. Outcome events (death, MI, revascularization, stent thrombosis) will be evaluated at 1,
           6, and 12 months by clinic visits or phone calls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>1 year</time_frame>
    <description>All cases of deaths from cardiovascular causes will be counted at 1 year.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Admission for urgent coronary revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>All events of hospital readmission for repeat coronary intervention for acute coronary syndrome from the time of discharge from hospital up to 1 year will be documented.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>All cases of definite/probable/possible stent thrombosis will be documented from the time of stent implantation during the index admission to 1 year.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline risk factors and outcome after 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>Several factors at baseline will be evaluated as potential contributors to adverse outcome after one year, including: age, gender, renal impairment, heart failure, CRUSADE bleeding risc score, GRACE risk score, diabetes, multiple risk factors, BMI, and smoking.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adherence to guidelines in patients undergoing PCI</measure>
    <time_frame>1 year</time_frame>
    <description>Using medications (statins, antiplatelets, ACI inhibitors/ARBs, B blockers, etc),and diagnostic and interventional procedures, and reaching target parameters (LDL cholesterol and HbA1c) according to the published guidelines will be evaluated.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2000</enrollment>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>PCI patients</arm_group_label>
    <description>Patients undergoing PCI for elective or ACS will be enrolled.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Procedure: PCI</intervention_name>
    <arm_group_label>PCI patients</arm_group_label>
    <other_name>PCI (percutaneous coronary intervention)will be performed according to cardiologists discretion, with no randomization of stent types or medications.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with acute coronary syndrome and stable coronary syndromes undergoing
        PCI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive PCI patients

          -  Arab nationality

        Exclusion Criteria:

          -  less than 18 year of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istishari Hospital</name>
      <address>
        <city>Amman</city>
        <zip>11954</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2013</study_first_submitted>
  <study_first_submitted_qc>April 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2013</study_first_posted>
  <last_update_submitted>January 7, 2017</last_update_submitted>
  <last_update_submitted_qc>January 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Outcome after PCI</keyword>
  <keyword>Middle Eastern Patients</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

